Results: GHK-Cu alleviated weight loss, improved the disease activity index (DAI), reduced colonic edema and shortening, attenuated inflammatory damage, increased goblet cell numbers, suppressed inflammatory cytokines such as TNF-, IL-6, and IL-1, and promoted mucosal repair
If you are exploring peptide therapy and experiencing changes in mood, anxiety, or cognitive function, a clinical evaluation can help determine the most appropriate course of action
While GLP-1 drugs are capturing headlines, they aren't the only medications approved for weight loss
Tirzepatide is a newer synthetic peptide that binds two incretin receptors at once: GLP-1 and GIP (glucose-dependent insulinotropic polypeptide)
Ozempic is a prescription medication approved for treating type 2 diabetes